Proposed cuts to Medicaid will have significant impacts on the health industry. One area that will be heavily impacted by ...

On Sunday, President Trump posted to Truth Social that he planned on implementing a most-favored-nation policy for ...

The Avmapki Fakzynja Co-Pack marks the first FDA-approved treatment for adult patients with KRAS-mutated recurrent low-grade ...

Beyond technology, regulations weigh heavily on the minds of pharma executives. Four out of 10 leaders believe regulatory ...

While expressing a desire for revenue growth is common, understanding the “why” behind that intention is crucial. Delving ...

Interim results from the ongoing Phase III ASSURE trial demonstrated that Livdelzi maintained a consistent biochemical ...

Lilly announced several changes to its executive leadership team. 1 These changes are mostly related to the company’s ...

Will Pih, co-founder, Two Labs, explains how ongoing regulatory uncertainty is slowing clinical trial activity and hiring ...

The use of RWD data in place of placebo groups is improving various elements across the clinical trial space.

Chip Parkinson, CEO, GiftHealth, explains how AI-powered data integration is bringing new hope to patients by revealing ...

In an effort to combat the state’s shortage of primary care physicians, Blue Cross Blue Shield of Massachusetts is offering ...

With this is mind, Abbott announced a new program that combines one of the most popular sports in the world with education ...